If you’re a plumbing estimator, you know the drill: long nights with blueprint PDFs, measuring scales, flipping between ...

There was a great flurry of activity inside the Woody Williams Center for Advanced Learning and Careers on Wednesday morning ...

An East Texas man has been sentenced to life in prison after law enforcement found him naked in his bathroom with a phone ...

Cadence Bank's latest narrative update leaves its fair value estimate essentially unchanged at $42.70 per share, even as analyst sentiment fractures around the recently announced all stock sale to ...

With close to a decade of writing and editing experience, Maisha specializes in service journalism and has produced work in the lifestyle, financial services, real estate, and culture spaces. She uses ...

The Huntington disease gene was mapped to human chromosome 4p in 1983 and 10 years later the pathogenic mutation was identified as a CAG-repeat expansion. Our current understanding of the molecular ...

Deal to create bank with $276 billion in assets Banking M&A in 2025 accelerates Cadence shares up 5%, Huntington falls 2.5% Huntington eyes foothold in high-growth markets Dealmaking has gathered pace ...

Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and deadly neurodegenerative disorder, at his clinic at the University of Alabama at Birmingham. But a Wednesday in ...

Bryce Vissel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. A new potential gene ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...

An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported by the biotechnology company uniQure this week. Huntington’s is an ...